InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Anderson Daniel Griffith. Director active across 1 company, notably Sigilon Therapeutics, Inc.. Aggregated, 1 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €1.6m. Activity tracked since 2 June 2021. The latest transaction was filed on 2 June 2021 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration